Nifedipine Tablet, Extended Release
Product Images NDC 68071-2619

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68071-2619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2619 3)

NuCare Pharmaceuticals, Inc. presents a bottle of NIFEdipine 30mg Extended-Release tablets, containing 30mg of Nifedipine per tablet, packaged in a bottle with lot number 00000 and serial number 0000000002. Each yellow round tablet is debossed with the number 30 on one side and is film-coated for extended-release. The bottle contains 30 tablets and should be stored at a controlled temperature of 68-77°F. Any potential side effects must be reported to a doctor or the FDA immediately, and the tablets must be kept out of reach of children. The product is available by prescription only.*

FDA Label Image

01 (Image 01)

FDA Label Image

02 (Image 02)

This is a table showing the percentage of individuals who experienced adverse effects while taking Nifedipine extended-release tablets compared to a placebo. The adverse effects listed include headache, fatigue, dizziness, constipation, and nausea. The table indicates that a higher percentage of individuals experienced constipation and nausea while taking Nifedipine compared to the placebo. Additionally, a higher percentage experienced headache while taking Nifedipine, though the difference was not as significant. Fatigue and dizziness were both experienced at similar percentages between the two groups.*

FDA Label Image

03 (Image 03)

This is a table comparing the adverse effects of taking Nifedipine capsules versus a placebo. The table shows the percentage of patients (out of 226 and 235) who experienced each of the listed side effects. The side effects include dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*

FDA Label Image

04 (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.